Owners, management and financials
CVR: 20045078
Secondary names: ZEALAND PHARMACEUTICALS A/S
Previous names: ApS KBUS 8 NR. 4581, PEPTIDE PROBE TECHNOLOGIES ApS, ZEALAND PHARMACEUTICALS A/S
DKK 9,214,860,000
Revenue
Net result: DKK 6,455,008,000
ZEALAND PHARMA A/S (5-9,99%), Van Herk Investments B.V. (5-9,99%)
4 more
CVR · view owners
Adam Sinding Steensberg, Henriette Wennicke
Board: Alf Gunnar Martin Nicklasson (chair) and 14 members
CVR · view management
Active
Founded 1 April 1997
CVR · view overview
569 employees
CVR · 2026
Owner registered: ZEALAND PHARMA A/S
CVR · 21/08/2026
View the full event history
ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 569 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.
Source: annual report 2025, Danish Business Authority
Zealand Pharma A/S has shown a remarkable turnaround in its financial health, achieving a profit of 6.46 billion DKK in 2025, a significant recovery from the losses of previous years. Revenue surged to 9.21 billion DKK in 2025, compared to just 62.69 million DKK in 2024, indicating a strong growth trajectory. The company’s equity has also improved substantially, reaching 14.83 billion DKK, reflecting a solid financial foundation. For the first half of 2026, Zealand Pharma reported revenues of 4.53 billion DKK and a profit of 3.52 billion DKK, suggesting it is on track to exceed its previous full-year results. Overall, the company appears well-positioned within the life sciences industry, bolstered by its improving margins and equity position.
AI-generated summary · Generated 18/08/2026
Selskabets formål er at drive forskning, produktion, handel og dermed beslægtet virksomhed, primært indenfor medicinalbranchen.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 9.2 mia. | 6.5 mia. | 15.9 mia. | 14.8 mia. | 418 | |
| 202401/01/2024 – 31/12/2024 | 62.7 mio. | -1.1 mia. | 9.5 mia. | 8.6 mia. | 235 | |
| 202301/01/2023 – 31/12/2023 | 342.8 mio. | -703.7 mio. | 2 mia. | 1.6 mia. | 235 | |
| 202201/01/2022 – 31/12/2022 | 104 mio. EUR | -1.2 mia. EUR | 1.5 mia. EUR | 815.9 mio. EUR | 247 | |
| 202101/01/2021 – 31/12/2021 | 292.6 mio. | -1 mia. | 2.1 mia. | 927.8 mio. | 346 | |
| 202001/01/2020 – 31/12/2020 | 353.3 mio. | -846.7 mio. | 1.8 mia. | 1.2 mia. | 297 | |
| 201901/01/2019 – 31/12/2019 | 41.3 mio. | -571.5 mio. | 1.6 mia. | 1.2 mia. | - | |
| 201801/01/2018 – 31/12/2018 | 38 mio. | 581.3 mio. | 1.2 mia. | 1.1 mia. | - | |
| 201701/01/2017 – 31/12/2017 | 139.8 mio. | -272.3 mio. | 737.2 mio. | 528.5 mio. | - | |
| 201601/01/2016 – 31/12/2016 | 234.8 mio. | -153.9 mio. | 694.6 mio. | 278.2 mio. | - | |
| 201501/01/2015 – 31/12/2015 | 187.7 mio. | -114 mio. | 634.7 mio. | 252.2 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 153.8 mio. | -65 mio. | 596.8 mio. | 252.8 mio. | - |
Daily closing prices, Nasdaq Copenhagen
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of ZEALAND PHARMA A/S is 20045078.
The owners of ZEALAND PHARMA A/S include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V..
The management of ZEALAND PHARMA A/S consists of Adam Sinding Steensberg and Henriette Wennicke.
The board of ZEALAND PHARMA A/S consists of Alf Gunnar Martin Nicklasson, Kirsten Aarup Drejer and Adam Krisko Nygaard, with Alf Gunnar Martin Nicklasson as chair.
In 2025, ZEALAND PHARMA A/S reported revenue of DKK 9,214,860,000.
ZEALAND PHARMA A/S had 569 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 88773600, new email: [email protected], new website: http://www.zealandpharma.com (September 11, 2026).
Contact info changed: new phone: 88773600, new email: [email protected], new website: http://www.zealandpharma.com (August 24, 2026).
As of August 21, 2026, ZEALAND PHARMA A/S is registered as an owner of ZEALAND PHARMA A/S with an ownership share of 5%.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2026 – June 30, 2026.
Contact info changed: new phone: 88773600, new email: [email protected], new website: http://www.zealandpharma.com (June 9, 2026).
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2026 – March 31, 2026.
Contact info changed: new phone: 88773600, new email: [email protected], new website: http://www.zealandpharma.com (May 26, 2026).
As of May 26, 2026, Camilla Sylvest has joined the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its annual report for 2025. Revenue came to DKK 9,214,860,000, and the net result was DKK 6,455,008,000.
Contact info changed: new phone: 88773600, new email: [email protected], new website: http://www.zealandpharma.com (March 27, 2026).
Contact info changed: new phone: 88773600, new email: [email protected], new website: http://www.zealandpharma.com (March 26, 2026).
As of March 26, 2026, Iris Katharina Löw-Friedrich has joined the board of directors of ZEALAND PHARMA A/S.
As of March 26, 2026, Jeffrey Berkowitz has left the board of directors of ZEALAND PHARMA A/S.
As of March 26, 2026, Bernadette Mary Connaughton has left the board of directors of ZEALAND PHARMA A/S.
Contact info changed: new phone: 88773600, new email: [email protected], new website: http://www.zealandpharma.com (March 20, 2026).
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2025 – September 30, 2025.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2025 – June 30, 2025.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2025 – March 31, 2025.
ZEALAND PHARMA A/S has published its annual report for 2024. Revenue came to DKK 62,691,000, and the net result was DKK -1,078,828,000.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2024 – September 30, 2024.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2024 – June 30, 2024.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2024 – March 31, 2024.
ZEALAND PHARMA A/S has published its annual report for 2023. Revenue came to DKK 342,788,000, and the net result was DKK -703,739,000.
As of March 20, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ZEALAND PHARMA A/S.
As of March 20, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ZEALAND PHARMA A/S.
As of March 20, 2024, EY Godkendt Revisionspartnerselskab has stepped down as auditor of ZEALAND PHARMA A/S.
As of March 20, 2024, Ludovic Tranholm Otterbein has joined the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Nikolaj Frederik Beck has joined the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Adam Krisko Nygaard has joined the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Tanja Lund Erichsen has joined the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Katja Haaber Løje Hansen has joined the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Lars Elmelund Pedersen has joined the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Cecilie Kold has joined the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Elaine Sullivan has joined the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Enrique Alfredo Conterno Martinelli has joined the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Jens Peter Stenvang has left the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Jacob Ulrik Fog has left the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Iben Louise Gjelstrup has left the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Alain Munoz has left the board of directors of ZEALAND PHARMA A/S.
As of March 20, 2024, Michael John Owen has left the board of directors of ZEALAND PHARMA A/S.
As of March 19, 2024, Nikolaj Frederik Beck has left the board of directors of ZEALAND PHARMA A/S.
As of January 25, 2024, is registered as an owner of ZEALAND PHARMA A/S with an ownership share of 5%.
As of January 25, 2024, is registered as an owner of ZEALAND PHARMA A/S.
As of January 8, 2024, is registered as an owner of ZEALAND PHARMA A/S with an ownership share of 5%.
As of January 8, 2024, is registered as an owner of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2023 – September 30, 2023.
As of October 19, 2023, is registered as an owner of ZEALAND PHARMA A/S with an ownership share of 5%.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2023 – June 30, 2023.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2023 – March 31, 2023.
ZEALAND PHARMA A/S has published its annual report for 2022. Revenue came to DKK 103,986,000, and the net result was DKK -1,202,135,000.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2022 – September 30, 2022.
As of November 1, 2022, Henriette Wennicke is registered as director of ZEALAND PHARMA A/S.
As of August 31, 2022, Matthew Donald Dallas has stepped down as director of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2022 – March 31, 2022.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2022 – June 30, 2022.
ZEALAND PHARMA A/S has published its annual report for 2021. Revenue came to DKK 292,567,000, and the net result was DKK -1,018,149,000.
As of March 30, 2022, Adam Sinding Steensberg is registered as adm. dir. of ZEALAND PHARMA A/S.
As of March 30, 2022, Emmanuel Dulac has stepped down as adm. dir. of ZEALAND PHARMA A/S.
As of March 29, 2022, Adam Sinding Steensberg has stepped down as director of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2021 – September 30, 2021.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2021 – June 30, 2021.
As of September 1, 2021, Anneline Nansen has joined the board of directors of ZEALAND PHARMA A/S.
As of September 1, 2021, Gertrud Koefoed Rasmussen has left the board of directors of ZEALAND PHARMA A/S.
As of August 31, 2021, Anneline Nansen has left the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its annual report for 2020. Revenue came to DKK 353,314,000, and the net result was DKK -846,729,000.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2020 – June 30, 2020.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2020 – March 31, 2020.
ZEALAND PHARMA A/S has published its annual report for 2019. Revenue came to DKK 41,333,000, and the net result was DKK -571,541,000.
As of April 2, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of ZEALAND PHARMA A/S.
As of April 2, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ZEALAND PHARMA A/S.
As of April 2, 2020, Gertrud Koefoed Rasmussen has joined the board of directors of ZEALAND PHARMA A/S.
As of April 2, 2020, Jacob Ulrik Fog has joined the board of directors of ZEALAND PHARMA A/S.
As of April 2, 2020, Nikolaj Frederik Beck has joined the board of directors of ZEALAND PHARMA A/S.
As of April 2, 2020, Iben Louise Gjelstrup has joined the board of directors of ZEALAND PHARMA A/S.
As of April 2, 2020, Hanne Heidenheim Bak has left the board of directors of ZEALAND PHARMA A/S.
As of April 2, 2020, Christian Thorkildsen has left the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period July 1, 2019 – September 30, 2019.
As of October 25, 2019, Matthew Donald Dallas is registered as director of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its annual report for 2018. Revenue came to DKK 37,977,000, and the net result was DKK 581,282,000.
As of April 22, 2019, Adam Sinding Steensberg is registered as director of ZEALAND PHARMA A/S.
As of April 22, 2019, Emmanuel Dulac is registered as adm. dir. of ZEALAND PHARMA A/S.
As of April 22, 2019, Emmanuel Dulac is registered as adm. dir. of ZEALAND PHARMA A/S.
As of April 22, 2019, Emmanuel Dulac has stepped down as adm. dir. of ZEALAND PHARMA A/S.
As of April 21, 2019, Adam Sinding Steensberg has stepped down as adm. dir. of ZEALAND PHARMA A/S.
As of April 4, 2019, Kirsten Aarup Drejer has joined the board of directors of ZEALAND PHARMA A/S.
As of April 4, 2019, Jeffrey Berkowitz has joined the board of directors of ZEALAND PHARMA A/S.
As of April 4, 2019, Leonard Kruimer has joined the board of directors of ZEALAND PHARMA A/S.
As of April 4, 2019, Bernadette Mary Connaughton has joined the board of directors of ZEALAND PHARMA A/S.
As of April 4, 2019, Rosemary Crane has left the board of directors of ZEALAND PHARMA A/S.
As of April 4, 2019, Catherine Moukheibir has left the board of directors of ZEALAND PHARMA A/S.
As of April 3, 2019, Kirsten Aarup Drejer has left the board of directors of ZEALAND PHARMA A/S.
As of March 28, 2019, Mats Blom has stepped down as director of ZEALAND PHARMA A/S.
As of February 28, 2019, Adam Sinding Steensberg is registered as adm. dir. of ZEALAND PHARMA A/S.
As of February 28, 2019, Britt Meelby Jensen has stepped down as adm. dir. of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period July 1, 2018 – September 30, 2018.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2018 – June 30, 2018.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2018 – March 31, 2018.
ZEALAND PHARMA A/S has published its annual report for 2017. Revenue came to DKK 139,775,000, and the net result was DKK -272,271,000.
As of April 19, 2018, Kirsten Aarup Drejer has joined the board of directors of ZEALAND PHARMA A/S.
As of April 10, 2018, Helle Haxgart has left the board of directors of ZEALAND PHARMA A/S.
As of April 10, 2018, Anne Kragh Sager has left the board of directors of ZEALAND PHARMA A/S.
As of December 1, 2017, Helle Haxgart has joined the board of directors of ZEALAND PHARMA A/S.
As of December 1, 2017, Rasmus Just has left the board of directors of ZEALAND PHARMA A/S.
As of November 30, 2017, Helle Haxgart has left the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2017 – September 30, 2017.
As of August 31, 2017, Helle Størum has left the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2017 – June 30, 2017.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2017 – March 31, 2017.
ZEALAND PHARMA A/S has published its annual report for 2016. Revenue came to DKK 234,778,000, and the net result was DKK -153,910,000.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2016 – June 30, 2016.
ZEALAND PHARMA A/S has published its interim report for the period July 1, 2016 – September 30, 2016.
ZEALAND PHARMA A/S has published its interim report for the period April 1, 2016 – June 30, 2016.
As of June 2, 2016, James Peter Arthur Benson has left the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2016 – March 31, 2016.
ZEALAND PHARMA A/S has published its annual report for 2015. Revenue came to DKK 187,677,000, and the net result was DKK -113,957,000.
As of April 19, 2016, Hanne Heidenheim Bak has joined the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2016, Helle Haxgart has joined the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2016, Helle Størum has joined the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2016, Christian Thorkildsen has joined the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2016, Rasmus Just has joined the board of directors of ZEALAND PHARMA A/S.
As of April 18, 2016, Hanne Heidenheim Bak has left the board of directors of ZEALAND PHARMA A/S.
As of April 18, 2016, Helle Størum has left the board of directors of ZEALAND PHARMA A/S.
As of April 18, 2016, Christian Thorkildsen has left the board of directors of ZEALAND PHARMA A/S.
As of April 14, 2016, Anne Kragh Sager has joined the board of directors of ZEALAND PHARMA A/S.
As of April 14, 2016, Anneline Nansen has joined the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2015 – September 30, 2015.
ZEALAND PHARMA A/S has published its interim report for the period April 1, 2015 – June 30, 2015.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2015 – March 31, 2015.
ZEALAND PHARMA A/S has published its annual report for 2014. Revenue came to DKK 153,773,000, and the net result was DKK -64,990,000.
As of April 21, 2015, Alf Gunnar Martin Nicklasson has joined the board of directors of ZEALAND PHARMA A/S.
As of April 21, 2015, Rosemary Crane has joined the board of directors of ZEALAND PHARMA A/S.
As of April 21, 2015, Catherine Moukheibir has joined the board of directors of ZEALAND PHARMA A/S.
As of April 21, 2015, Jørgen Lindegaard has left the board of directors of ZEALAND PHARMA A/S.
As of April 21, 2015, Daniël Jan Ellens has left the board of directors of ZEALAND PHARMA A/S.
As of February 2, 2015, Florian Nicolas Christian Reinaud has left the board of directors of ZEALAND PHARMA A/S.
As of January 15, 2015, Britt Meelby Jensen is registered as adm. dir. of ZEALAND PHARMA A/S.
As of January 15, 2015, David Horn Solomon has stepped down as adm. dir. of ZEALAND PHARMA A/S.
As of December 31, 2014, Søren Vitfell Keller has left the board of directors of ZEALAND PHARMA A/S.
As of December 31, 2014, Maria Juul Kolding has left the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its annual report for 2013.
As of April 29, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ZEALAND PHARMA A/S.
As of April 29, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ZEALAND PHARMA A/S.
As of April 29, 2014, Søren Vitfell Keller has joined the board of directors of ZEALAND PHARMA A/S.
As of April 29, 2014, Hanne Heidenheim Bak has joined the board of directors of ZEALAND PHARMA A/S.
As of April 29, 2014, Jens Peter Stenvang has joined the board of directors of ZEALAND PHARMA A/S.
As of April 29, 2014, Maria Juul Kolding has joined the board of directors of ZEALAND PHARMA A/S.
As of April 29, 2014, Jutta Grevinde af Rosenborg has left the board of directors of ZEALAND PHARMA A/S.
As of April 29, 2014, Hanne Heidenheim Bak has left the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its annual report for 2012.
As of April 30, 2013, Jørgen Lindegaard has joined the board of directors of ZEALAND PHARMA A/S.
As of April 30, 2013, Daniël Jan Ellens has joined the board of directors of ZEALAND PHARMA A/S.
As of March 15, 2013, Christian Grøndahl has stepped down as director of ZEALAND PHARMA A/S.
As of January 30, 2013, John Hyttel has stepped down as director of ZEALAND PHARMA A/S.
As of April 25, 2012, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ZEALAND PHARMA A/S.
As of April 25, 2012, A/S PSE NR. 2857 has stepped down as auditor of ZEALAND PHARMA A/S.
As of April 25, 2012, Hanne Heidenheim Bak has joined the board of directors of ZEALAND PHARMA A/S.
As of April 25, 2012, Michael John Owen has joined the board of directors of ZEALAND PHARMA A/S.
As of April 28, 2011, Jutta Grevinde af Rosenborg has joined the board of directors of ZEALAND PHARMA A/S.
As of April 28, 2011, James Peter Arthur Benson has joined the board of directors of ZEALAND PHARMA A/S.
As of April 28, 2011, Christian Herskind Jørgensen has left the board of directors of ZEALAND PHARMA A/S.
As of April 28, 2010, Florian Nicolas Christian Reinaud has joined the board of directors of ZEALAND PHARMA A/S.
As of April 28, 2010, Helle Størum has left the board of directors of ZEALAND PHARMA A/S.
As of April 28, 2010, Christian Thorkildsen has left the board of directors of ZEALAND PHARMA A/S.
As of April 7, 2010, Christian Grøndahl is registered as director of ZEALAND PHARMA A/S.
As of April 7, 2010, John Hyttel is registered as director of ZEALAND PHARMA A/S.
As of April 7, 2010, Mats Blom is registered as director of ZEALAND PHARMA A/S.
As of April 7, 2010, Mogens Ibenfeldt has stepped down as director of ZEALAND PHARMA A/S.
As of January 31, 2010, Anders Vadsholt has left the board of directors of ZEALAND PHARMA A/S.
As of January 21, 2010, Thomas Tscherning has left the board of directors of ZEALAND PHARMA A/S.
As of November 30, 2009, Jean Christophe Renondin has left the board of directors of ZEALAND PHARMA A/S.
As of April 30, 2009, Anders Vadsholt has joined the board of directors of ZEALAND PHARMA A/S.
As of April 7, 2009, Linda Sjøstrøm has left the board of directors of ZEALAND PHARMA A/S.
As of October 3, 2008, Thomas Tscherning has joined the board of directors of ZEALAND PHARMA A/S.
As of October 3, 2008, Jens William Kindtler has left the board of directors of ZEALAND PHARMA A/S.
As of September 4, 2008, Mogens Ibenfeldt is registered as director of ZEALAND PHARMA A/S.
As of September 4, 2008, David Horn Solomon is registered as adm. dir. of ZEALAND PHARMA A/S.
As of May 26, 2008, Helle Størum has joined the board of directors of ZEALAND PHARMA A/S.
As of May 26, 2008, Helle Størum has joined the board of directors of ZEALAND PHARMA A/S.
As of May 26, 2008, Lone Skjøttgaard Due has left the board of directors of ZEALAND PHARMA A/S.
As of April 30, 2008, Jørgen Søberg Petersen has stepped down as director of ZEALAND PHARMA A/S.
As of April 29, 2008, Christian Herskind Jørgensen has joined the board of directors of ZEALAND PHARMA A/S.
As of April 29, 2008, Marlene Nørgaard Carolus has left the board of directors of ZEALAND PHARMA A/S.
As of December 21, 2007, Linda Sjøstrøm has joined the board of directors of ZEALAND PHARMA A/S.
As of December 21, 2007, Jens William Kindtler has joined the board of directors of ZEALAND PHARMA A/S.
As of December 7, 2007, Jesper Zeuthen has left the board of directors of ZEALAND PHARMA A/S.
As of November 30, 2007, Eva Steiness has stepped down as adm. dir. of ZEALAND PHARMA A/S.
As of June 15, 2007, Alain Munoz has joined the board of directors of ZEALAND PHARMA A/S.
As of June 15, 2007, Gudmund Tyge Korsgaard has left the board of directors of ZEALAND PHARMA A/S.
As of June 15, 2007, Rémi Droller has left the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2007, Jesper Zeuthen has joined the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2007, Lars Kolind has left the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2007, Bo Lennart Bruce has left the board of directors of ZEALAND PHARMA A/S.
As of February 18, 2007, Jan Honoré has left the board of directors of ZEALAND PHARMA A/S.
As of September 1, 2006, Jørgen Søberg Petersen is registered as director of ZEALAND PHARMA A/S.
As of June 30, 2006, Marlene Nørgaard Carolus has joined the board of directors of ZEALAND PHARMA A/S.
As of February 22, 2006, Jean Christophe Renondin has joined the board of directors of ZEALAND PHARMA A/S.
As of February 22, 2006, Rémi Droller has joined the board of directors of ZEALAND PHARMA A/S.
As of February 22, 2006, Thierry Claude Laugel has left the board of directors of ZEALAND PHARMA A/S.
As of February 22, 2006, Dr Alain Munoz has left the board of directors of ZEALAND PHARMA A/S.
As of January 1, 2006, Christian Thorkildsen has joined the board of directors of ZEALAND PHARMA A/S.
As of January 1, 2006, Christian Thorkildsen has joined the board of directors of ZEALAND PHARMA A/S.
As of December 31, 2005, Ketil Jørgen Haugan has left the board of directors of ZEALAND PHARMA A/S.
As of May 26, 2005, Lars Kolind has joined the board of directors of ZEALAND PHARMA A/S.
As of May 26, 2005, Dr Alain Munoz has joined the board of directors of ZEALAND PHARMA A/S.
As of May 26, 2005, Patrick John Paul Coleman has left the board of directors of ZEALAND PHARMA A/S.
As of May 26, 2005, Eva Steiness is registered as adm. dir. of ZEALAND PHARMA A/S.
As of February 17, 2005, Thierry Claude Laugel has joined the board of directors of ZEALAND PHARMA A/S.
As of February 17, 2005, Bent Benny Andersen has left the board of directors of ZEALAND PHARMA A/S.
As of May 11, 2004, Ketil Jørgen Haugan has joined the board of directors of ZEALAND PHARMA A/S.
As of May 11, 2004, Jan Honoré has joined the board of directors of ZEALAND PHARMA A/S.
As of May 11, 2004, Lone Skjøttgaard Due has joined the board of directors of ZEALAND PHARMA A/S.
As of May 11, 2004, Tom Larsen has left the board of directors of ZEALAND PHARMA A/S.
As of June 4, 2003, Niels Erik Nielsen has left the board of directors of ZEALAND PHARMA A/S.
As of May 21, 2003, Bent Benny Andersen has joined the board of directors of ZEALAND PHARMA A/S.
As of May 21, 2003, Tom Larsen has joined the board of directors of ZEALAND PHARMA A/S.
As of May 21, 2003, Gudmund Tyge Korsgaard has joined the board of directors of ZEALAND PHARMA A/S.
As of May 21, 2003, Patrick John Paul Coleman has joined the board of directors of ZEALAND PHARMA A/S.
As of May 21, 2003, Bo Lennart Bruce has joined the board of directors of ZEALAND PHARMA A/S.
As of May 21, 2003, Jørgen Buus Lassen has left the board of directors of ZEALAND PHARMA A/S.
As of December 19, 2002, Leif Helth Jensen has left the board of directors of ZEALAND PHARMA A/S.
As of May 7, 2002, Michael Thomas Sember has left the board of directors of ZEALAND PHARMA A/S.
On May 7, 2002, the company changed its name from ZEALAND PHARMACEUTICALS A/S to ZEALAND PHARMA A/S.
As of November 12, 2001, Leslie Lars Iversen has left the board of directors of ZEALAND PHARMA A/S.
As of June 13, 2001, A/S PSE NR. 2857 has been appointed auditor of ZEALAND PHARMA A/S.
As of June 13, 2001, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of ZEALAND PHARMA A/S.
As of August 21, 2000, Michael Thomas Sember has joined the board of directors of ZEALAND PHARMA A/S.
As of June 29, 2000, Leslie Lars Iversen has joined the board of directors of ZEALAND PHARMA A/S.
As of December 22, 1998, Niels Erik Nielsen has joined the board of directors of ZEALAND PHARMA A/S.
As of December 22, 1998, Jørgen Buus Lassen has joined the board of directors of ZEALAND PHARMA A/S.
As of December 22, 1998, Leif Helth Jensen has joined the board of directors of ZEALAND PHARMA A/S.
On October 20, 1998, the company changed its name from PEPTIDE PROBE TECHNOLOGIES ApS to ZEALAND PHARMACEUTICALS A/S.
As of October 19, 1998, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of ZEALAND PHARMA A/S.
As of October 19, 1998, PEDER KRISTIAN MØLLER ApS has stepped down as auditor of ZEALAND PHARMA A/S.
As of October 19, 1998, Dan Buxbom has left the board of directors of ZEALAND PHARMA A/S.
As of October 19, 1998, Leif Helth Jensen has left the board of directors of ZEALAND PHARMA A/S.
As of January 6, 1998, Dan Buxbom has joined the board of directors of ZEALAND PHARMA A/S.
As of January 6, 1998, Leif Helth Jensen has joined the board of directors of ZEALAND PHARMA A/S.
On August 23, 1997, the company changed its name from ApS KBUS 8 NR. 4581 to PEPTIDE PROBE TECHNOLOGIES ApS.
As of August 22, 1997, PEDER KRISTIAN MØLLER ApS has been appointed auditor of ZEALAND PHARMA A/S.
As of August 22, 1997, JUT NR. 2180 A/S has stepped down as auditor of ZEALAND PHARMA A/S.
As of August 22, 1997, Per Emil Hasselbalch Stakemann has stepped down as director of ZEALAND PHARMA A/S.
As of April 1, 1997, JUT NR. 2180 A/S has been appointed auditor of ZEALAND PHARMA A/S.
As of April 1, 1997, Per Emil Hasselbalch Stakemann is registered as director of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S was founded on April 1, 1997.
6 news items and press releases
Sources: Via Ritzau and Danish news media. Links open at the source.
Companies in the same industry and area
CVR 37918806
CVR 45943062
CVR 41093447
CVR 45576310
CVR 34173427
